Home›Companies›Biotech & Pharma›CARGO Therapeutics

CARGO Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 1, 2023·Suggest an edit

About CARGO Therapeutics

CARGO Therapeutics is a private company based in San Mateo, California, incorporated in 2019 in Delaware. It has reported $68,832,003 raised in one offering on Form D since March 2023. Its chief executive is Gina Chapman.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 9, 2023Mar 1, 2023$68,832,003of $200.7M target19$3.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CARGO Therapeutics's Form D filed Mar 1, 2023.

GC
Gina Chapman
Chief Executive Officer and director
AB
Abraham Bassan
Director
Also a director at Septerna.
JW
CM
HL
Heath Lukatch
Director
Also a chairman of the board at Magnus.
JO
John Orwin
Director
AR
Anup Radhakrishnan
Executive officer

Sources

  1. SECCARGO Therapeutics, Inc. filing history